Therefore, our findings, along with new studies focusing on APE1 and STAT3, could support identifying new promising pharmacological inhibitors for these proteins and contribute to the development of enhanced therapeutic strategies against cancer, including breast cancer. This evidence concerns the gene APEX1 and breast carcinoma.